Complicated Monkeypox Infection in a Patient With Multiple Sclerosis and Fingolimod Treatment

被引:2
|
作者
Mueller-Jensen, Leonie [1 ,3 ,4 ,5 ]
Kriedemann, Helene [2 ]
Anvari, Kerstin
Huehnchen, Petra [1 ,3 ,4 ,5 ]
Siffrin, Volker [1 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
关键词
D O I
10.1212/WNL.0000000000206743
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 46-year old man with controlled relapsing-remitting multiple sclerosis (MS) and long-term fingolimod treatment developed multiple painful skin lesions (Figure, A). Outpatient skin swab revealed monkeypox virus infection. No fever was detected, but the disease course was complicated by prolonged cutaneous, oral and perianal manifestations, proctitis (Figure, B), gastrointestinal bleeding with the need for blood transfusions, lower leg phlegmon (Figure, C), lymphadenopathy, and hyperbilirubinemia. Furthermore, the patient presented acute urinary retention and hematuria.
引用
收藏
页码:670 / 671
页数:2
相关论文
共 50 条
  • [31] Multiple sclerosis: Fingolimod is an effective oral treatment for MS
    Jones N.
    Nature Reviews Neurology, 2010, 6 (3) : 121 - 121
  • [32] THE COST EFFECTIVENESS OF FINGOLIMOD FOR THE TREATMENT MULTIPLE SCLEROSIS IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [33] Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
    Thomas, Katja
    Proschmann, Undine
    Ziemssen, Tjalf
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1649 - 1660
  • [34] Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
    Bascunana, Pablo
    Mohle, Luisa
    Brackhan, Mirjam
    Pahnke, Jens
    DRUGS IN R&D, 2020, 20 (03) : 197 - 207
  • [35] Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis
    Walker, Susan
    Brew, Bruce
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 31 : 217 - 218
  • [36] Tumefactive multiple sclerosis lesions associated with fingolimod treatment
    Sanchez, P.
    Meca-Lallana, V.
    Aguirre, C.
    Dotor, J.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1020 - 1021
  • [37] Drug satisfaction in multiple sclerosis using fingolimod treatment
    Terzi, M.
    Evin, O.
    Terzi, Y.
    Sen, S.
    Ecem, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1058 - 1059
  • [38] Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
    Pablo Bascuñana
    Luisa Möhle
    Mirjam Brackhan
    Jens Pahnke
    Drugs in R&D, 2020, 20 : 197 - 207
  • [39] TUMEFACTIVE MULTIPLE SCLEROSIS LESIONS UNDER FINGOLIMOD TREATMENT
    Visser, Femke
    Wattjes, Mike P.
    Pouwels, Petra J. W.
    Linssen, Wim H. J. P.
    van Oosten, Bob W.
    NEUROLOGY, 2012, 79 (19) : 2000 - 2002
  • [40] Fingolimod: a novel oral immunomodulatory treatment for multiple sclerosis
    Javed, Adil
    Soliven, Betty
    FUTURE NEUROLOGY, 2011, 6 (03) : 315 - 325